Schedule 13G ownership disclosure
OAKTREE ACQUISITION CORP I-A
Class A ordinary shares, par value $0.0001 · CUSIP: G6717R104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Oaktree Acquisition Holdings III LS, LLC
Shares: 5,500,535 · Class: 22.3%
- Oaktree Acquisition Holdings III LS GP, Ltd.
Shares: 5,500,535 · Class: 22.3%
- Oaktree Capital Holdings, LLC
Shares: 5,500,535 · Class: 22.3%
- Oaktree Capital Group Holdings GP, LLC
Shares: 5,500,535 · Class: 22.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-019260
- Form type
- SCHEDULE 13G
- Filer
- Oaktree Acquisition Corp. III Life Sciences
- CIK
- CIK 2029769
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership